The U.S. Food and Drug Administration has historically maintained a tight grip on international regulatory priorities to prevent them from drifting away from its own preferences. This level of control is necessary because the global medical device industry currently operates within a fragmented
The intersection of rapid technological disruption and a purging of the federal workforce has created a policy vacuum that threatens the nation's response to synthetic viruses. Current shifts in the American national security posture indicate a systematic dismantling of the biological defense
The proliferation of over one thousand high-containment laboratories in the United States since 9/11 has paradoxically increased the mathematical probability of a catastrophic accident. This startling statistic serves as the foundation for Annie Jacobsen’s investigation into the burgeoning threat
Strategic location within the Houston biotech hub provides Bristol Myers Squibb with access to a robust ecosystem of talent, infrastructure, and academic partnerships. This massive $2.3 billion investment represents a definitive shift toward securing the domestic supply chain and modernizing the
This digital initiative addresses long-standing inefficiencies by providing a public mechanism to verify the legal status of medical devices sold throughout the country. For many years, the Mexican medical device market struggled with a lack of transparency, where paper-based records led to
Maintaining medicinal consistency across a global network requires navigating a labyrinth of geopolitical shifts and varying international regulatory expectations. The journey of a pharmaceutical product from a manufacturing plant to a patient’s local pharmacy is an intricate operation governed by
